Your browser doesn't support javascript.
loading
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina, Valeria; Bruscaggin, Alessio; Cuccaro, Annarosa; Martini, Maurizio; Di Trani, Martina; Forestieri, Gabriela; Manzoni, Martina; Condoluci, Adalgisa; Arribas, Alberto; Terzi-Di-Bergamo, Lodovico; Locatelli, Silvia Laura; Cupelli, Elisa; Ceriani, Luca; Moccia, Alden A; Stathis, Anastasios; Nassi, Luca; Deambrogi, Clara; Diop, Fary; Guidetti, Francesca; Cocomazzi, Alessandra; Annunziata, Salvatore; Rufini, Vittoria; Giordano, Alessandro; Neri, Antonino; Boldorini, Renzo; Gerber, Bernhard; Bertoni, Francesco; Ghielmini, Michele; Stüssi, Georg; Santoro, Armando; Cavalli, Franco; Zucca, Emanuele; Larocca, Luigi Maria; Gaidano, Gianluca; Hohaus, Stefan; Carlo-Stella, Carmelo; Rossi, Davide.
Afiliación
  • Spina V; Institute of Oncology Research, Bellinzona, Switzerland.
  • Bruscaggin A; Institute of Oncology Research, Bellinzona, Switzerland.
  • Cuccaro A; Institute of Hematology and.
  • Martini M; Division of Pathology, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Di Trani M; Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy.
  • Forestieri G; Institute of Oncology Research, Bellinzona, Switzerland.
  • Manzoni M; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Condoluci A; Institute of Oncology Research, Bellinzona, Switzerland.
  • Arribas A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Terzi-Di-Bergamo L; Institute of Oncology Research, Bellinzona, Switzerland.
  • Locatelli SL; Institute of Oncology Research, Bellinzona, Switzerland.
  • Cupelli E; Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy.
  • Ceriani L; Institute of Hematology and.
  • Moccia AA; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stathis A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Nassi L; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Deambrogi C; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Diop F; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Guidetti F; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Cocomazzi A; Institute of Oncology Research, Bellinzona, Switzerland.
  • Annunziata S; Division of Pathology, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Rufini V; Institute of Nuclear Medicine, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Giordano A; Institute of Nuclear Medicine, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Neri A; Institute of Nuclear Medicine, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Boldorini R; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Gerber B; Hematology Unit, Foundation Ca' Granda IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.
  • Bertoni F; Division of Pathology, Department of Health Science, University of Eastern Piedmont, Novara, Italy; and.
  • Ghielmini M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stüssi G; Institute of Oncology Research, Bellinzona, Switzerland.
  • Santoro A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Cavalli F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Zucca E; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Larocca LM; Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy.
  • Gaidano G; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Hohaus S; Institute of Oncology Research, Bellinzona, Switzerland.
  • Carlo-Stella C; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Rossi D; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Blood ; 131(22): 2413-2425, 2018 05 31.
Article en En | MEDLINE | ID: mdl-29449275
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Neoplasia Residual / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Neoplasia Residual / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos